Thanks, Mike. I'd like to begin by sharing a few highlights of our financial results for the quarter. Total revenue was approximately $56 million, and NOI was approximately $45.4 million. Net loss attributable to common shareholders was approximately $3.8 million, or $0.11 per share, inclusive of a $6.5 million non-cash impairment related to a pending other segment sale. Same store cash NOI was approximately $44.2 million, a 1.7% increase compared to the same quarter last year. But for a rent abatement in the 11th year of a pre-existing lease in our industrial segment, same-store cash NOI would have grown by 4.2%. The abatement period for this lease continues through November 2024. FFO, as defined by NAREIT, was approximately $25.6 million, or $0.65 per share, on a fully diluted basis and AFFO was approximately $27.6 million, or $0.70 per share, on a fully diluted basis. Moving on to our balance sheet. As Mike mentioned, at quarter-end, we were in a great position to execute on our credit facility extension, given our strong balance sheet and high-quality portfolio. Subsequent to quarter end, we used a portion of our cash to pay down the credit facility, and simultaneously completed this amendment and extension, which leaves us with ample liquidity and flexibility to support our industrial growth initiatives. Key terms of the amended facility are as follows. We now have a total facility of $907 million, comprised of a $547 million revolver, a $210 million term loan, and a $150 million term loan. The maturity dates of the revolver and the $210 million term loan were extended four years from closing to July, 2028. The maturity date of the $150 million term loan remains April, 2026. The weighted average term to maturity for the credit facility is now 3.6 years. The rates are SOFR-based, with applicable spreads ranging from 125 to 165 basis points. Given our $750 million of interest rate swaps at a weighted average rate of 1.97%, 100% of our current outstanding debt is now fixed through July 1, 2025. Based on our current consolidated leverage ratio, our weighted average effective interest rate for the entire facility is 3.67%, inclusive of our current swaps. Subsequent to quarter end, we purchased $550 million of four-year forward interest rate swaps, effective July 1, 2025, when our current swaps expire through July 1, 2029, at a weighted average rate of 3.58%. We are pleased that we were able to swap $550 million of our variable rate debt for an additional four-year period at 3.58%. When we purchased these forward swaps, the current one-month term SOFR was approximately 5.33%. The amended facility also provides an improved valuation for our industrial assets included in the borrowing-based calculation. These assets are now valued at a 6% cap rate rather than 7% previously. I would now like to discuss certain financial impacts as a result of closing the extension. As of 6-30, prior to the extension, we had cash of $447 million, with the majority of our cash earning interest in the 5% range for approximately $4.6 million of interest income in the second quarter. Accordingly, at quarter end, our net debt-to-normalized EBITDA RE ratio was 5.9 times. In connection with the closing of the extension, we used $200 million to pay down the unhedged portion of the credit facility and incurred $13 million of one-time transaction costs. The $213 million of cash generated approximately $2.7 million of interest income in the second quarter. It's important to note that in the near term, the prospective interest expense savings more than offsets the interest income earned previously on this cash. With that said, our pro forma metrics reflecting the closing of the amended facility are as follows. Cash of approximately $234 million, available revolver capacity of approximately $157 million, total liquidity of approximately $391 million, consolidated net debt balance of approximately $980 million, consolidated weighted average interest rate for all debt, secured and unsecured, 3.96%, and pro forma net debt to normalized EBITDA RE ratio of 6.4 times, reflecting the $213 million cash utilization and associated reduction of interest income. For the second quarter, we paid a dividend of $0.225 per common share in July. And the Board of Trustees approved a third quarter dividend of $0.225 per share payable on October 17 to holders of record on September 30. While the company expects to continue paying dividends on a quarterly basis, all future dividend decisions will continue to be made by the Board of Trustees. With that, I will pass the call back to Mike.